Tufts Medical Center
35 Kneeland St.
Boston, MA 02111
Phone #: 617-636-5866
Fax #: 617-636-2369
2015-18, "Top Doctor," Boston Magazine
2014-18, "Highly Cited Researcher," Thomson Reuters/Clarivate Analytics
2016, Member, Association of American Physicians
2013, Belding H. Scribner Award from the American Society of Nephrology
2013, Distinguished Alumnus Award, Boston University School of Medicine
2012, David M. Hume Award from the National Kidney Foundation
2011, NKF Spring on the Park Gala honoree
2007, Faculty Recognition Award (25 years of service) from Tufts University School of Medicine
2004, Distinguished Faculty Award from Tufts University School of Medicine
1999, Faculty Recognition Award, Tufts University
Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, Greene T, Tighiouart H, Matsushita K, Ballew SH, Sang Y, Vonesh E, Ying J, Manley T, de Zeeuw D, Eckardt K-U, Levin A, Perkovic V, Zhang L, Willis K. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of Chronic Kidney Disease: A Scientific Workshop sponsored by the National Kidney Foundation (NKF) in collaboration with the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA). Am J Kidney Dis (2019, in review)
Freed TA, Coresh J, Inker LA, Toal DR, Perichon R, Chen J, Goodman KD, Zhang Q, Conner JK, Hauser DM, Vroom KET, Oyaski ML, Wulff JE, Eiriksdóttir G, Gudnason V, Torres VE, Ford LA, Levey AS. Validation of a metabolite panel for a more accurate estimation of glomerular filtration rate using quantitative LC-MS/MS. Clin Chem 2019; 65:406-418. Epub 2019 Jan 15; PMID:30647123.
Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, Chodick G, Collins AJ, Djurdjev O, Elley CR, Evans M, Garg AX, Hallan SI, Inker LA, Ito S, Jee SH, Kovesdy CP, Kronenberg F, Lambers Heerspink HJ, Marks A, Nadkami GN, Navaneethan SD, Nelson RG, Titze S, Sarnak MJ, Stengal B, Woodward M, Iseki K, for the CKD Prognosis Consortium. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA 2016; 315:164-174; PMID:26757465.
Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, Chow EKH, Kasiske BL, Kovesdy CP, Nadkarni GN, Shalev V, Segev DL, Coresh J, Lentine KL, Garg AX, for the Chronic Kidney Disease Prognosis Consortium. Kidney-failure projection for the living kidney-donor candidate. New Engl J Med 2016; 374:411-421. Epub 2015 Nov 9; PMID:26544982.
Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA 2015; 313:837-846 (includes Appendix published online); PMID:25710660.
Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, de Zeeuw, Cheung AK, Coresh J. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2014; 64:821-835.
Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Dis 2014; 63:820-834. Epub 2014 Jan 28; PMID:24485147.
Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, for the CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013; 369:932-943.
Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS, for the CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012;367:20-9.
Levey AS, Coresh J. Chronic kidney disease. Lancet; Epub 2011 Aug 15; doi:10.1016/50140-673(11)60178-5.
Chronic Kidney Disease Consortium (Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073-2081. PMCID:PMC3993088; PMID:20483451.
Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Edkardt KU. The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80:17-28.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Int Med 2009; 150:604-612. PMCID:PMC2763564; PMID:19414839.
Dr. Levey’s research interests include measurement and estimation of kidney function, epidemiology and clinical trials in chronic kidney disease (CKD). For the past 20 years, he has been at the forefront of the development of equations to estimate glomerular filtration rate (GFR) from serum creatinine, cystatin C and novel filtration markers using large databases, including the widely-used Modification of Diet in Renal Disease (MDRD) Study and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations. He leads CKD-EPI and is a founding member of the Chronic Kidney Disease Prognosis Consortium (CKD-PC). The use of GFR estimating equations to estimate kidney function and inform prognosis has transformed research, clinical practice, and public health in CKD.
Dr. Levey is a widely recognized authority on clinical practice guidelines in CKD and has contributed to guideline development, implementation, quality improvement and public policy in this area. He has trained a large cadre of clinical researchers in nephrology, and led the Division’s NIDDK-supported training grant (T32) in clinical trials, epidemiology and outcomes research from 1999-2018. He was Editor-in-Chief of the American Journal of Kidney Diseases from 2007-2016.